Antilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depression

Journal of Psychosomatic Research
Heidi T MayElizabeth Joy

Abstract

An association between depression and coronary artery disease (CAD) is well established. Poor adherence to cardiac treatments may be one way depression could contribute to the increased risk of coronary events among depressed patients. We sought to evaluate whether adherence to antilipid medication, a therapy shown to be beneficial in secondary prevention of coronary events, differs among CAD patients with and without an ICD-9 depression diagnosis. Patients were included if, at angiography, they were determined to have CAD (stenosis >or=70%), were discharged on an antilipid medication, and re-filled their prescriptions at a participating pharmacy. A patient was determined to have depression (ICD-9 codes 296.2-296.36, 311) if the diagnosis occurred prior to angiography or within 6 months of the CAD diagnosis. Adherence and long-term outcomes were evaluated at 6 months, 1 year, 18 months and 2 years. A total of 585 patients were included, with 73 (12.5%) having a diagnosis of depression prior to or within 6 months of CAD diagnosis. At all time-points, those with depression had a lower mean adherence compared to those without depression. Differences in adherence rates after adjustment were 7% (P=.001), 6% (P=.02), 13% (P<.0001) an...Continue Reading

References

Jun 1, 1987·The Gerontologist·D BlazerL K George
Mar 22, 1984·The New England Journal of Medicine·UNKNOWN CASS Principal Investigators and Their Associates
Nov 30, 2002·Lancet·James ShepherdUNKNOWN PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Jul 10, 2003·General Hospital Psychiatry·Paul S CiechanowskiIrl B Hirsch
Nov 27, 2004·Psychosomatic Medicine·Jürgen BarthChristoph Herrmann-Lingen
Oct 20, 2005·Journal of Epidemiology and Community Health·Oscar H FrancoLuc Bonneux
Dec 22, 2005·American Heart Journal·Sonali P KulkarniEric D Peterson
Oct 13, 2006·Journal of Occupational and Environmental Medicine·Xue SongRonald J Ozminkowski
Dec 13, 2006·Journal of the American College of Cardiology·Nina RieckmannKarina W Davidson
Jan 31, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Andrew M PetersonMichael Nichol

❮ Previous
Next ❯

Citations

Apr 6, 2011·Cardiology in Review·Christopher M Celano, Jeff C Huffman
Jun 6, 2014·AIDS Patient Care and STDs·Shuntai ZhouDavid A Wohl
Feb 10, 2016·Nigerian Journal of Clinical Practice·S B GöktasO Gur
Jul 14, 2010·Journal of Psychosomatic Research·Roy C Ziegelstein, Brian Howard
May 9, 2013·Cardiovascular Psychiatry and Neurology·Jeff C HuffmanJames L Januzzi
Apr 2, 2013·Clinical Therapeutics·Anne M LibbyJan D Hirsch
Jan 22, 2013·Journal of Psychosomatic Research·Christian DempeJobst-Hendrik Schultz
Apr 30, 2013·Progress in Cardiovascular Diseases·Benjamin A RodwinJoseph A Ladapo
May 24, 2014·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Linda G ParkKathleen Dracup
Nov 14, 2012·European Journal of Preventive Cardiology·Alyna TurnerMarian U C Worcester
Nov 13, 2018·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Brittanny M PolankaJesse C Stewart
Jul 6, 2018·Harvard Review of Psychiatry·Christopher M CelanoJeff C Huffman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.